GlassScriptPhysician profile
Ethan N Goldstein
NPI 1336357219
$140,039.07
in general payments reported to CMS, 2019-2025
15 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58K · 2020: $55K · 2021: $4,820 · 2022: $21K · 2023: $386 · 2024: $179 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $133,985.84 | 2019-2025 | Advincula Delineator Uterine Manipulator, Endosee, Mara Console |
| Intuitive Surgical, INC. | $4,220.78 | 2019-2021 | |
| Acessa Health INC. | $542.74 | 2021 | |
| Hologic Sales and Service, LLC | $388.05 | 2019-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device |
| Abbott Laboratories | $278.49 | 2021 | |
| Uroviu Corporation | $175.22 | 2023 | Uro-G Flexible Cystoscope |
| Biogen, INC. | $100.00 | 2025 | Zurzuvae |
| Averitas Pharma INC. | $95.37 | 2024 | Qutenza |
| Aspira Women'S Health INC | $75.00 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $54.18 | 2025 | |
| Myovant Sciences INC. | $39.39 | 2021 | |
| Hologic INC | $30.00 | 2021 | |
| Minerva Surgical, INC | $23.57 | 2019 | |
| Millicent US INC | $15.36 | 2025 | Intrarosa, Femring |
| Pfizer INC. | $15.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.